European Medicines Agency

The EU will recognise national Covid certificates from Turkey, Ukraine and North Macedonia from Friday, opening the way to easier travel for their residents, the European Commission said.

The "equivalence decisions" mean those three countries' certificates will be connected to the bloc-wide EU Digital Covid Certificate system, the EU executive said in a statement.

Ljubljana – A total of 199 coronavirus infections were confirmed in Slovenia on Thursday in 1,841 PCR tests for a positivity rate of 10.8%. The cumulative 14-day incidence per 100,000 residents continued to steadily increase, standing at 92, up by four on the day before, show fresh data by the National Institute of Public Health (NIJZ).

As of August 1, the programming platform for immunisation against COVID-19 will allow young people aged between 12 and 17 to register for vaccination with the serum produced by Moderna - Spikevax.

Head of the National COIVID-19 Vaccination Coordination Committee (CNCAV) Valeriu Gheorghita said on Tuesday in September there will very likely be a decision on the administration of a third dose of COVID-19 vaccine to people at high risk of exposure, such as the healthcare workers, people with chronic diseases, those over 65 years of age.

Head of the National COVID-19 Vaccination Coordination Committee (CNCAV) Valeriu Gheorghita said on Tuesday that from August 2, in Romania, 12 to 17-year-olds will be able to be immunised against COVID-19 with the vaccine produced by Moderna, with appointments being available in the vaccination platform starting on August 1.

Chairman of Romania's National COVID-19 Vaccination Coordination Committee (CNCAV) Valeriu Gheorghita says that a decision will be made next week on the possibility of a heterologous vaccination regimen against COVID-19 that combines two vaccines with different technologies.

Ljubljana – Alpelizib, the only targeted therapy for a specific type of advanced breast cancer, is now accessible to patients in Slovenia, making it one of the few countries where it is available. The Institute of Oncology already started treating patients in the compassionate use programme before the drug was registered.

A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published on June 13.

Marco Cavaleri, the EMA's head of vaccine strategy, also told Italy's La Stampa newspaper that the Johnson & Johnson jab should be preferentially used for the over 60s.

Ljubljana – The head of the national advisory group for Covid-19 vaccination, Bojana Beović, has said that following the European Medicines Agency’s (EMA) approval of the Pfizer/BioNTech vaccine for children aged 12 or more, the group will recommend vaccinating children, especially children suffering from chronic diseases.

Immunisation against COVID-19 of 12- 15 year olds with the Pfizer/BioNTech vaccine could start on Wednesday, conditional upon all procedural criteria imposed by the European Medicines Agency (EMA) being met according to the agreed timetable.